Cryoprecipitated anti-hemophilic factor (cryo)

Definition

Cryoprecipitated anti-hemophilic factor (cryo) is a blood product derived from plasma, rich in clotting factors like fibrinogen and Factor VIII. It is used to treat patients with hemophilia, von Willebrand disease, and other bleeding disorders.

5 Must Know Facts For Your Next Test

1. Cryo contains essential clotting factors such as fibrinogen, Factor VIII, von Willebrand factor, and Factor XIII.
2. It is typically administered intravenously in a hospital setting to control or prevent bleeding.
3. Cryo must be stored at temperatures below -18°C to maintain its efficacy.
4. The product is derived from pooled plasma donations and undergoes rigorous screening to ensure safety.
5. Patients receiving cryo should be monitored for allergic reactions and transfusion-related complications.

Review Questions

• What are the primary components found in cryoprecipitated anti-hemophilic factor?
• How should cryo be stored to maintain its effectiveness?
• What conditions can be treated using cryoprecipitated anti-hemophilic factor?

Related terms

Plasma: The liquid component of blood that carries cells and proteins throughout the body.

Factor VIII: A blood-clotting protein that is deficient in individuals with hemophilia A.

Von Willebrand Disease: A genetic disorder caused by missing or defective von Willebrand factor, a clotting protein.